Table 6.
Parameters | Healthy control (n=8) | AFB1 (n=8) | AFB1+IV BM-MSCs (n=8) | AFB1+IH BM-MSCs (n=8) | AFB1+IV HDCs (n=8) | AFB1+IH HDCs (n=8) | p-value |
---|---|---|---|---|---|---|---|
GSH (nmol/mL) | 33.51±2.64 | 20.18*±3.73 | 32.86a±2.11 | 27.55±3.09 | 23.76±1.65 | 30.33a±2.17 | 0.0125 |
TAC (mM/L) | 1.76+0.24 | 0.48**+0.03 | 1.54b+0.36 | 0.76+0.03 | 0.54+0.08 | 0.56+0.07 | 0.0331 |
In the same row,
and
are significantly different than control at P<0.05 and P<0.01 respectively and
and
are significantly different than AFB1 at P<0.05 and P<0.01, respectively. AFB1=Aflatoxin B1, IV=Intravenous, IH=Intrahepatic, BM-MSCs=Bone marrow mesenchymal stem cells, HDCs=Hepatogenic differentiated cells, GSH=Reduced glutathione, TAC=Total antioxidant capacity